WILLIAM J CAIRE

Allopathic & Osteopathic Physicians|Family Medicine RICHARDSON, TX NPI 1891784492

General Payments — all program years on this page

$395.18

  • Category: General Payments
  • Program years: PY2023–2024
  • Record count: 22
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $375.37 across 21 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $375.3721

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2023 $19.811
2024 $375.3721

Records — PY2024 (21)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1096593674 Novo Nordisk Inc $21.56 06/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1096714531 Novo Nordisk Inc $17.15 02/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1096895937 Novo Nordisk Inc $18.07 01/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1097046069 Novo Nordisk Inc $22.90 03/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1097234684 Novo Nordisk Inc $18.11 04/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1097511904 Novo Nordisk Inc $21.53 08/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1097585386 Novo Nordisk Inc $9.04 12/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1097826491 Novo Nordisk Inc $14.58 03/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1097832407 Novo Nordisk Inc $15.14 07/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104534971 AstraZeneca Pharmaceuticals LP $17.97 07/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105356387 AstraZeneca Pharmaceuticals LP $14.37 11/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1110788771 Eisai Inc. $22.89 05/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1114605083 Exact Sciences Corporation $22.30 11/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116476338 GlaxoSmithKline, LLC. $13.85 11/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1118221243 Boehringer Ingelheim Pharmaceuticals, Inc. $23.19 02/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1118221247 Boehringer Ingelheim Pharmaceuticals, Inc. $25.27 05/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135442147 Lilly USA, LLC $13.91 11/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135499638 Lilly USA, LLC $17.20 03/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135506576 Lilly USA, LLC $15.20 04/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135506578 Lilly USA, LLC $14.09 09/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1153344017 Dexcom, Inc. $17.05 07/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.